Stem Cells, Cell and Gene Therapy Biotechs to Discuss Capital Formation Strategies and Validation
NEW YORK – In a progressive cell therapy environment that has decreasing clinical attrition, next generation and next-to-launch biotechs along with regulators, will be talking about current… Read more »